Saemundur Rögnvaldsson

23PUBLICATIONS

42CO-AUTHORS

Medical mycologyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jul 14, 2026

Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.

|Jul 06, 2026

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

|Apr 11, 2026

Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.

Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson

|Apr 08, 2026

Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study.

Styrmir Hallsson, Ingibjorg Gunnarsdottir, Marianna Thordardottir

|Mar 30, 2026

Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.

Lærke Sloth Andersen, Cecilie Velsø Mæng, Sæmundur Rögnvaldsson

|Oct 10, 2025

Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group.

Sigrún Thorsteinsdóttir, Konstantinos Lemonakis, Tobias S Slørdahl

Pageof 4

Frequent Collaborators

20 joint publications

Sigrún Þorsteinsdóttir

17 joint publications

Sigurður Yngvi Kristinsson

12 joint publications

Ola Landgren

10 joint publications

Jón Þórir Óskarsson

8 joint publications

Gauti Kjartan Gíslason

7 joint publications

Thorir Einarsson Long

7 joint publications

Malin Hultcrantz

6 joint publications

Runolfur Palsson

4 joint publications

Asbjorn Jonsson